Please assess the completion status of the following clinical trial:

Trial Title: Droxidopa in Treating Patients With Neurogenic Hypotension

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
PROTOCOL ENTRY CRITERIA:~--Disease Characteristics--~* Orthostatic hypotension due to autonomic nervous system failure Fall in systolic blood pressure (supine to standing) of at least 20 mm Hg and diastolic blood pressure of at least 15 mm Hg AND Symptoms of hypotension such as dizziness, light-headedness, unsteadiness, dimming or blurred vision~* History of syncope or near-syncope~--Prior/Concurrent Therapy--~* Endocrine therapy: No concurrent adrenergics Concurrent fludrocortisone allowed~* Other: Concurrent indomethacin, support garments, and high salt diets allowed

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).